<code id='58E585D704'></code><style id='58E585D704'></style>
    • <acronym id='58E585D704'></acronym>
      <center id='58E585D704'><center id='58E585D704'><tfoot id='58E585D704'></tfoot></center><abbr id='58E585D704'><dir id='58E585D704'><tfoot id='58E585D704'></tfoot><noframes id='58E585D704'>

    • <optgroup id='58E585D704'><strike id='58E585D704'><sup id='58E585D704'></sup></strike><code id='58E585D704'></code></optgroup>
        1. <b id='58E585D704'><label id='58E585D704'><select id='58E585D704'><dt id='58E585D704'><span id='58E585D704'></span></dt></select></label></b><u id='58E585D704'></u>
          <i id='58E585D704'><strike id='58E585D704'><tt id='58E585D704'><pre id='58E585D704'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:83
          Adobe

          Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

          Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

          advertisement

          Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

          DanSkovronsky,EliLilly'schiefscientificofficer,atthe2023STATSummit.STATPHILADELPHIA—Inasense,theannu

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Carbon Health diabetes program, a test of data

          AdobeAdiabetesdiagnosiswasnotwhatJasonhadinmindwhenhesetoutonacross-countryroadtripwithhisfamilyinth